I. Federici

A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi.

R. Fanin, F. Gherlinzoni, P. Chiusolo, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease‐free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy

F. Marchegiani, A. Offidani, G. Ganzetti, 2012, The British journal of dermatology.

Severe COVID‐19 in a patient with chronic graft‐versus‐host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib

P. Bagnarelli, A. Olivieri, I. Scortechini, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides

N. Pimpinelli, A. Zizzi, G. Filosa, 2016, European Journal of Dermatology.

Conditioning Regimens for Frail Patients with Acute Leukemia Undergoing Allogeneic Stem Cell Transplant: How to Strike Gently

Maria Vittoria Dubbini, A. Olivieri, I. Scortechini, 2021, Clinical hematology international.

Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: the role of the WHO histological diagnosis

A. Zizzi, A. Scortechini, G. Goteri, 2015, Diagnostic Pathology.

Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature

G. Polonara, E. Inglese, A. Olivieri, 2021, Bone Marrow Transplantation.

Low Dose Bexarotene and Ultraviolet A Photochemotherapy (PUVA) In a Prospective Phase II Clinical Study for Refractory and/or Resistant Cutaneous T Cell Lymphomas (CTCL)

N. Pimpinelli, S. Pulini, A. Scortechini, 2010 .